...
首页> 外文期刊>Human Pathology >Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
【24h】

Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.

机译:诊断双色可分离发色原位杂交的诊断工具,用于检测福尔马林固定,石蜡包埋的滑膜肉瘤中重排的SS18。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pathological diagnosis of synovial sarcoma is often problematic due to its broad spectrum of histology. Because synovial sarcoma consistently carries a specific chromosomal translocation, t(X;18), and its derivative chimeric gene, either SS18-SSX1 or SS18-SSX2, detecting these abnormalities by reverse transcription polymerase chain reaction or fluorescence in situ hybridization has been recognized as a powerful aid for diagnosis. Recently, chromogenic in situ hybridization, which enables simultaneous visualization of both genomic abnormality and the morphology of tumor cells, has gained attention. This study investigated the diagnostic utility of dual-color break-apart chromogenic in situ hybridization as a novel method for detecting SS18 rearrangement in synovial sarcoma. Formalin-fixed, paraffin-embedded tissue samples from 16 cases of synovial sarcoma and 10 cases of 5 other types of soft tissue sarcoma were collected. Dual-color break-apart probes were designed against the genomic region adjacent to SS18. Fluorescence and chromogenic in situ hybridization studies were performed using the same sections. In both assays, the number of signals was counted for sixty nuclei per sample. Scoring ratios (unpaired signals/paired signals) were calculated. Subsequently, SS18-SSX1 and SS18-SSX2 were examined by reverse transcription polymerase chain reaction. The results of chromogenic in situ hybridization, fluorescence in situ hybridization, and reverse transcription polymerase chain reaction were correlated. Unpaired signals were clearly observed in all the synovial sarcoma samples, which mostly indicated rearranged SS18. Synovial sarcoma and non-synovial sarcoma samples were clearly distinguished from each other by the scoring ratios. Reverse transcription polymerase chain reaction demonstrated SS18 chimeric gene transcripts in all the synovial sarcoma cases, while no fusion genes were detected in the non-synovial sarcoma cases. Taken together, unpaired signals in synovial sarcoma reflected rearranged SS18. The present chromogenic in situ hybridization-based SS18 rearrangement detection system provides a highly sensitive and specific method for the diagnosis of synovial sarcoma. Chromogenic in situ hybridization-based methods have great potential for routine use in the diagnosis of synovial sarcoma.
机译:滑膜肉瘤的病理学诊断由于其组织学范围广而常常存在问题。由于滑膜肉瘤始终携带特定的染色体易位t(X; 18)及其衍生的嵌合基因SS18-SSX1或SS18-SSX2,因此通过逆转录聚合酶链反应或荧光原位杂交检测这些异常对诊断的有力帮助。最近,能够同时可视化基因组异常和肿瘤细胞形态的生色原位杂交受到关注。这项研究调查了双色断裂显色原位杂交的诊断效用,作为一种检测滑膜肉瘤SS18重排的新方法。从16例滑膜肉瘤和10例5种其他类型的软组织肉瘤中收集福尔马林固定,石蜡包埋的组织样品。针对靠近SS18的基因组区域设计了双色断裂探针。使用相同的切片进行荧光和生色原位杂交研究。在两种测定中,每个样本计数了60个核的信号数量。计算得分比(未配对信号/配对信号)。随后,通过逆转录聚合酶链反应检查SS18-SSX1和SS18-SSX2。显色原位杂交,荧光原位杂交和逆转录聚合酶链反应的结果是相关的。在所有滑膜肉瘤样品中清楚地观察到未配对的信号,这主要表明SS18已重新排列。滑膜肉瘤和非滑膜肉瘤样品之间的评分比率可以清楚地区分。逆转录聚合酶链反应在所有滑膜肉瘤病例中均显示SS18嵌合基因转录本,而在非滑膜肉瘤病例中未检测到融合基因。滑膜肉瘤中未配对的信号合在一起反映了重新排列的SS18。本发明的基于显色原位杂交的SS18重排检测系统为滑膜肉瘤的诊断提供了高度灵敏和特异性的方法。基于生色原位杂交的方法在滑膜肉瘤的诊断中具有常规应用的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号